Yongqi Liu - Search Results

Year	Number of Results
2005	1
2007	1
2009	1
2013	3
2014	3
2015	2
2017	2
2018	6
2019	9
2020	13
2021	11
2022	25
2023	38
2024	17

1

A Review of the Pharmacological Action of Astragalus Polysaccharide.

Zheng Y, Ren W, Zhang L, Zhang Y, Liu D, Liu Y. Zheng Y, et al. Among authors: liu y. Front Pharmacol. 2020 Mar 24;11:349. doi: 10.3389/fphar.2020.00349. eCollection 2020. Front Pharmacol. 2020. PMID: 32265719 Free PMC article. Review.

2

Spatial transcriptomics reveals light-induced chlorenchyma cells involved in promoting shoot regeneration in tomato callus.

Song X, Guo P, Xia K, Wang M, Liu Y, Chen L, Zhang J, Xu M, Liu N, Yue Z, Xu X, Gu Y, Li G, Liu M, Fang L, Deng XW, Li B. Song X, et al. Among authors: liu y. Proc Natl Acad Sci U S A. 2023 Sep 19;120(38):e2310163120. doi: 10.1073/pnas.2310163120. Epub 2023 Sep 13. Proc Natl Acad Sci U S A. 2023. PMID: 37703282 Free PMC article.

3

Delivery of CD47 blocker SIRPα-Fc by CAR-T cells enhances antitumor efficacy.

Chen H, Yang Y, Deng Y, Wei F, Zhao Q, Liu Y, Liu Z, Yu B, Huang Z. Chen H, et al. Among authors: liu y. J Immunother Cancer. 2022 Feb;10(2):e003737. doi: 10.1136/jitc-2021-003737. J Immunother Cancer. 2022. PMID: 35110357 Free PMC article.

4

Engineering photocatalytic ammonia synthesis.

Shi Y, Zhao Z, Yang D, Tan J, Xin X, Liu Y, Jiang Z. Shi Y, et al. Among authors: liu y. Chem Soc Rev. 2023 Oct 16;52(20):6938-6956. doi: 10.1039/d2cs00797e. Chem Soc Rev. 2023. PMID: 37791542 Review.

5

Aquaporins: Important players in the cardiovascular pathophysiology.

Shangzu Z, Dingxiong X, ChengJun M, Yan C, Yangyang L, Zhiwei L, Ting Z, Zhiming M, Yiming Z, Liying Z, Yongqi L. Shangzu Z, et al. Among authors: yongqi l. Pharmacol Res. 2022 Sep;183:106363. doi: 10.1016/j.phrs.2022.106363. Epub 2022 Jul 26. Pharmacol Res. 2022. PMID: 35905892 Free article. Review.

6

Natural products targeting Nrf2/ARE signaling pathway in the treatment of inflammatory bowel disease.

Li B, Wang Y, Jiang X, Du H, Shi Y, Xiu M, Liu Y, He J. Li B, et al. Among authors: liu y. Biomed Pharmacother. 2023 Aug;164:114950. doi: 10.1016/j.biopha.2023.114950. Epub 2023 May 30. Biomed Pharmacother. 2023. PMID: 37263167 Free article. Review.

7

Inhibition of LPA-LPAR1 and VEGF-VEGFR2 Signaling in IPF Treatment.

Luo YL, Li Y, Zhou W, Wang SY, Liu YQ. Luo YL, et al. Drug Des Devel Ther. 2023 Sep 2;17:2679-2690. doi: 10.2147/DDDT.S415453. eCollection 2023. Drug Des Devel Ther. 2023. PMID: 37680863 Free PMC article. Review.

8

Review: Mechanisms and perspective treatment of radioresistance in non-small cell lung cancer.

Zhou T, Zhang LY, He JZ, Miao ZM, Li YY, Zhang YM, Liu ZW, Zhang SZ, Chen Y, Zhou GC, Liu YQ. Zhou T, et al. Front Immunol. 2023 Feb 14;14:1133899. doi: 10.3389/fimmu.2023.1133899. eCollection 2023. Front Immunol. 2023. PMID: 36865554 Free PMC article. Review.

9

Mechanisms of Alveolar Type 2 Epithelial Cell Death During Acute Lung Injury.

Qi X, Luo Y, Xiao M, Zhang Q, Luo J, Ma L, Ruan L, Lian N, Liu Y. Qi X, et al. Among authors: liu y. Stem Cells. 2023 Dec 14;41(12):1113-1132. doi: 10.1093/stmcls/sxad074. Stem Cells. 2023. PMID: 37715783 Review.

10

Guiqi Baizhu prescription ameliorates cytarabine-induced intestinal mucositis by targeting JAK2 to inhibit M1 macrophage polarization.

Chu W, Li YL, Li JJ, Lin J, Li M, Wang J, He JZ, Zhang YM, Yao J, Jin XJ, Cai H, Liu YQ. Chu W, et al. Biomed Pharmacother. 2023 Aug;164:114902. doi: 10.1016/j.biopha.2023.114902. Epub 2023 May 18. Biomed Pharmacother. 2023. PMID: 37209628 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

121 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

121 results

Results by year